NCT06724211View on ClinicalTrials.gov

Preventing Delayed Graft Function in Kidney Transplant Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

April 30, 2026

Conditions
Kidney TransplantKidney FailureKidney Injury
Interventions
OTHER

Treatment bundle of care

The treatment bundle of care will consist of: the use of plasmalyte for fluid management, maintaining mean arterial pressure \> 75 mmHg, identify and treat blood glucose \> 9 mmol/L, and a restrictive criteria for red blood cell transfusions (i.e. hemoglobin (Hb) \< 70 g/L).

OTHER

Control Group

Routine clinical care for kidney transplant patients

Trial Locations (2)

M5G 2C4

University Health Network, Toronto

Unknown

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT06724211 - Preventing Delayed Graft Function in Kidney Transplant Patients | Biotech Hunter | Biotech Hunter